REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $706,391 | -54.0% | 61,586 | +1.5% | 0.00% | -50.0% |
Q2 2023 | $1,534,950 | -22.6% | 60,646 | -1.5% | 0.00% | -20.0% |
Q1 2023 | $1,983,267 | +180197.0% | 61,573 | +3.4% | 0.01% | +66.7% |
Q4 2022 | $1,100 | -99.9% | 59,560 | +0.9% | 0.00% | -40.0% |
Q3 2022 | $1,594,000 | +17.9% | 59,044 | +21.7% | 0.01% | +66.7% |
Q3 2021 | $1,352,000 | +16.9% | 48,515 | +24.3% | 0.00% | 0.0% |
Q2 2021 | $1,157,000 | +51.8% | 39,027 | +43.1% | 0.00% | +50.0% |
Q1 2021 | $762,000 | +57.4% | 27,267 | +41.7% | 0.00% | 0.0% |
Q3 2020 | $484,000 | +26.0% | 19,244 | +22.3% | 0.00% | +100.0% |
Q2 2020 | $384,000 | -70.1% | 15,741 | -83.3% | 0.00% | -91.7% |
Q2 2016 | $1,283,000 | -30.8% | 94,308 | -11.3% | 0.01% | -33.3% |
Q1 2016 | $1,855,000 | -34.3% | 106,265 | +28.6% | 0.02% | -35.7% |
Q4 2015 | $2,822,000 | +36.5% | 82,610 | +18.9% | 0.03% | +27.3% |
Q3 2015 | $2,068,000 | +89.2% | 69,496 | +103.3% | 0.02% | +100.0% |
Q2 2015 | $1,093,000 | – | 34,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
Geduld E E | 25,001 | $850,000 | 0.53% |
Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |